MPG peptides: These peptides are widely used in the biomedical industry for drug delivery purposes. They enhance cellular uptake and promote efficient intracellular delivery of therapeutic drugs, making them indispensable in targeted therapies for various diseases, including cancer and viral infections. MPG peptides play a crucial role in overcoming cellular barriers and can significantly improve drug efficacy while minimizing toxicity.
CAT No: GR2205
CAS No: 1392498-36-0
Chemical Name: (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-1-[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[(2-aminoacetyl)amino]propanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]propanoyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]acetyl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]amino]hexanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoic acid
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C140H230N38O31S |
M.W/Mr. | 2973.63 |
InChI | InChI=1S/C140H230N38O31S/c1-74(2)60-98(127(197)174-106(68-88-70-152-90-43-28-27-42-89(88)90)133(203)176-107(72-179)134(204)166-97(50-51-110(145)181)137(207)178-58-37-49-109(178)136(206)165-93(46-31-34-55-143)122(192)161-91(44-29-32-53-141)120(190)160-92(45-30-33-54-142)121(191)162-94(47-35-56-150-139(146)147)123(193)163-95(48-36-57-151-140(148)149)124(194)177-113(80(13)14)138(208)209)159-112(183)71-153-119(189)96(52-59-210-20)164-128(198)103(65-79(11)12)172-135(205)108(73-180)175-130(200)102(64-78(9)10)168-117(187)84(18)156-114(184)82(16)155-115(185)83(17)157-125(195)99(61-75(3)4)170-131(201)104(66-86-38-23-21-24-39-86)169-118(188)85(19)158-126(196)100(62-76(5)6)171-132(202)105(67-87-40-25-22-26-41-87)173-129(199)101(63-77(7)8)167-116(186)81(15)154-111(182)69-144/h21-28,38-43,70,74-85,91-109,113,152,179-180H,29-37,44-69,71-73,141-144H2,1-20H3,(H2,145,181)(H,153,189)(H,154,182)(H,155,185)(H,156,184)(H,157,195)(H,158,196)(H,159,183)(H,160,190)(H,161,192)(H,162,191)(H,163,193)(H,164,198)(H,165,206)(H,166,204)(H,167,186)(H,168,187)(H,169,188)(H,170,201)(H,171,202)(H,172,205)(H,173,199)(H,174,197)(H,175,200)(H,176,203)(H,177,194)(H,208,209)(H4,146,147,150)(H4,148,149,151)/t81-,82-,83-,84-,85-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,113-/m0/s1 |
InChI Key | PHWWBNVPYIVKKX-LEBLOVRESA-N |
Canonical SMILES | CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)N3CCCC3C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)O)NC(=O)CNC(=O)C(CCSC)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CN |
Isomeric SMILES | C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N5CCC[C@H]5C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)CN |
1. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
3. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com